These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 29239973)

  • 1. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
    Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
    Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide attenuates induction and prevents progress of the 6-hydroxydopamine-induced Parkinsonism in rat through activation of ATP-sensitive potassium channels and suppression of ER stress.
    Minaei A; Sarookhani MR; Haghdoost-Yazdi H; Rajaei F
    Toxicol Appl Pharmacol; 2021 Jul; 423():115558. PubMed ID: 33961902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats.
    Yin WL; Yin WG; Huang BS; Wu LX
    Neurosci Lett; 2017 Sep; 657():45-52. PubMed ID: 28764908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model.
    Sarukhani MR; Haghdoost-Yazdi H; Khandan-Chelarci G
    Neurochem Res; 2018 May; 43(5):1086-1095. PubMed ID: 29616443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulphide attenuates neuronal apoptosis of substantia nigra by re-establishing autophagic flux via promoting leptin signalling in a 6-hydroxydopamine rat model of Parkinson's disease.
    Jiang W; Zou W; Hu M; Tian Q; Xiao F; Li M; Zhang P; Chen YJ; Jiang JM
    Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):122-133. PubMed ID: 34494284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.
    Baluchnejadmojarad T; Rabiee N; Zabihnejad S; Roghani M
    Brain Res; 2017 May; 1662():23-30. PubMed ID: 28238669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin mediates protection of hydrogen sulfide against 6-hydroxydopamine-induced Parkinson's disease: Involving enhancement in Warburg effect.
    Yang SQ; Tian Q; Li D; He SQ; Hu M; Liu SY; Zou W; Chen YJ; Zhang P; Tang XQ
    Neurochem Int; 2020 May; 135():104692. PubMed ID: 32032636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a 6-OHDA Induced Unilaterally Lesioned Male Wistar Rat Model of Parkinson's Disease.
    Kumari N; Luthra PM
    Methods Mol Biol; 2024; 2761():491-498. PubMed ID: 38427257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
    Jin F; Wu Q; Lu YF; Gong QH; Shi JS
    Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease.
    Farzam SA; Darabi S; Haghdoost-Yazdi H; Zaferani Y
    Neurol Res; 2024 Aug; 46(8):763-771. PubMed ID: 38740025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of hydrogen sulfide in a rat model of traumatic brain injury via activation of mitochondrial adenosine triphosphate-sensitive potassium channels and reduction of oxidative stress.
    Jiang X; Huang Y; Lin W; Gao D; Fei Z
    J Surg Res; 2013 Oct; 184(2):e27-35. PubMed ID: 23590867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease.
    Ferro MM; Angelucci ME; Anselmo-Franci JA; Canteras NS; Da Cunha C
    Braz J Med Biol Res; 2007 Jan; 40(1):89-96. PubMed ID: 17225001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.